(19)
(11)
EP 0 975 628 A1
(12)
(43)
Date of publication:
02.02.2000
Bulletin 2000/05
(21)
Application number:
98915368.9
(22)
Date of filing:
07.04.1998
(51)
International Patent Classification (IPC)
7
:
C07D
409/12
,
A61K
31/535
,
A61K
31/38
(86)
International application number:
PCT/US9806/989
(87)
International publication number:
WO 9845/286
(
15.10.1998
Gazette 1998/41)
(84)
Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU NL PT SE
Designated Extension States:
AL LT LV RO SI
(30)
Priority:
09.04.1997
US 43118 P
(71)
Applicant:
ELI LILLY AND COMPANY
Indianapolis, Indiana 46285 (US)
(72)
Inventor:
GLASEBROOK, Andrew, Lawrence
Zionsville, IN 46077 (US)
(74)
Representative:
Denholm, Anna Marie et al
Eli Lilly and Company Limited,Lilly Research Center,Erl Wood Manor
Windlesham,Surrey GU20 6PH
Windlesham,Surrey GU20 6PH (GB)
(54)
PREVENTION OF BREAST CANCER WITH SELECTIVE ESTROGEN RECEPTOR MODULATORS